Category Archives: Genetics

How ‘viral load’ and genetics could explain why young people have died from coronavirus – The Independent

The coronavirus pandemic has hit older people far harder than those who are younger, but scientists are yet to fully understand why this is.

Many of the elderly people who have died have had pre-existing health conditions such as heart disease, lung disease and diabetes, all of which make fighting the virus more difficult, but many have not had any such health problems, and occasionally the virus has caused the deaths of younger, apparently healthy people.

Researchers around the world are racing to learn how the virus behaves, which health factors put people most at risk, and are trying to work out whether there may be genetic traits that could mean some people respond to the infection differently to others.

Sharing the full story, not just the headlines

There are various theories to suggest why the virus is so unusually and devastatingly selective.

Some scientists have suggested the greater the amount of virus that infects an individual known as the viral load could make a large difference to how the body is able to respond to infection.

Put simply,the larger the dose of the virus a person gets, the worse the infection is, and the least promising the outcome.

A parallel school of thought is that genetic variations between humans differences in our DNA could affect how susceptible an individual is to the virus.

And another candidate for why apparently healthy young people are dying is they may have a highly reactive immune system, which is sent into overdrive fighting off the virus. In such a scenario, a huge inflammation storm could inadvertently overwhelm vital organs such as the lungs.

None of the theories compete with one another, and aspects of all of them, as well as innumerable other factors, could be at play in an individual case.

Viral load

No hype, just the advice and analysis you need

Dr Edward Parker of the London School of Hygiene and Tropical Medicine, explained how a high viral load can impact humans. He said: After we are infected with a virus, it replicates in our bodys cells. The total amount of virus a person has inside them is referred to as their viral load. For Covid-19, early reports from China suggest the viral load is higher in patients with more severe disease, which is also the case for Sars and influenza.

The amount of virus we are exposed to at the start of an infection is referred to as the infectious dose. For influenza, we know that that initial exposure to more virus or a higher infectious dose appears to increase the chance of infection and illness. Studies in mice have also shown that repeated exposure to low doses may be just as infectious as a single high dose.

He added: So all in all, it is crucial for us to limit all possible exposures to Covid-19, whether these are to highly symptomatic individuals coughing up large quantities of virus or to asymptomatic individuals shedding small quantities. And if we are feeling unwell, we need to observe strict self-isolation measures to limit our chance of infecting others.

Professor Wendy Barclay, the head of the Department of Infectious Disease at Imperial College London, said existing knowledge of viral load means healthcare workers can be at greater risk of infection.

In general with respiratory viruses, the outcome of infection whether you get severely ill or only get a mild cold can sometimes be determined by how much virus actually got into your body and started the infection off. Its all about the size of the armies on each side of the battle, a very large virus army is difficult for our immune systems army to fight off.

So standing further away from someone when they breathe or cough out virus likely means fewer virus particles reach you and then you get infected with a lower dose and get less ill. Doctors who have to get very close to patients to take samples from them or to intubate them are at higher risk so need to wear masks.

Genetic differences between those infected

Scientists are currently preparing to scour Covid-19 patients genomes for DNA variations that might indicate why some people are more at risk than others.

The findings could then be used to identify groups most at risk of serious illness and those who might be protected, and this knowledge could then inform the hunt for effective treatments.

A huge effort to pool DNA research from patients around the world is now on, with the ultimate goal being to build a body of evidence from people with no underlying health issues, but who have reacted differently to infection by the virus.

One promising strand of research into why some people are more susceptible to the coronavirus is on the gene variation for the cell surface protein angiotensin-converting enzyme 2 (ACE2), found on the outer membranes of cells, and which the coronavirus uses to enter cells in the lungs and airways.

Variations in production of ACE2 could make it easier or more difficult for the virus to enter and infect cells.

We see huge differences in clinical outcomes and across countries. How much of that is explained by genetic susceptibility is a very open question, geneticist Andrea Ganna, of the University of Helsinkis Institute for Molecular Medicine Finland, told Science Magazine.

Another fascinating line of inquiry is whether different blood types could lead to differing levels of susceptibility to the disease.

A Chinese research team reported in a non-peer-reviewed article that people with type O blood may be protected from the virus, and those with type A blood could be at greater risk.

Were trying to figure out if those findings are robust, Stanford University human geneticist Manuel Rivas told Science Magazine.

The first results from the investigations into genetic differences and susceptibility are expected in less than two months time.

Continued here:
How 'viral load' and genetics could explain why young people have died from coronavirus - The Independent

Genetics shed light on origins of Irish strains of Covid-19 – The Irish Times

Since the Covid-19 virus strain was first identified in early 2020, scientists have been able to track its progress around the world.

The virus is very slowly evolving, but in making copies of itself in its human hosts, it can introduce occasional errors in its genome sequence to make a different sequence.

This means that strains are almost identical but, crucially, differ by the tiniest amount. These tiny differences can be used as a kind of tracker to show how the virus has spread.

Scientists around the world have analysed more than 2,500 publicly shared Covid-19 genomes and identified 100-150 mutations.

They have been able to identify that the outbreak in Washington state, which was one of the earliest places in the United States to record coronavirus cases, came from China in early January and a second strain came from Europe.

The results are available on a public access platform called nextstrain.org where scientists share results from laboratory samples from those who contracted Covid-19.

Having analysed the nextstrain.org data, Irish scientist Prof James McInerney, the head of the school of life sciences at the University of Nottingham, has confirmed there is no single origin of viral strains in Ireland. However, he identified three potentially significant routes of transmission.

Testing laboratories in Dublin, Cork and Limerick each identified separate strains of the virus which were connected respectively to laboratories in Birmingham, Boston and Copenhagen.

While the strain identified in Dublin is associated with Birmingham, this does not mean the virus genome originated in Birmingham. Rather, it originated in the area covered by the testing laboratories based in the city.

This could include Cheltenham which is 80km south of Birmingham though there were cases in Dublin before thousands of Irish racegoers returned from the annual festival in early March.

Prof McInerney stressed it is not possible to say with any certainty that Cheltenham might have been a reservoir for the virus. The strain present in both Dublin and Birmingham could have originated in the Irish capital and been introduced to the UK, he noted.

All I can say is that there is a link we dont know the direction of transmission, only that there is a strong link.

The strain identified with Cork is the same as that from Boston which is understandable given the strong Irish links with the city. Massachusetts is a hot spot in the US for the illness with more than 7,000 cases and 122 deaths to date.

The direction of travel is unknown here too, so it might be the case that the Boston strain of the virus originated in Cork.

The third strain, which has been identified in Limerick, is the same as the one identified in laboratories in Copenhagen.

Prof McInerney said the connection with Copenhagen is more puzzling. It could be that somebody from Copenhagen brought the illness to Ireland, somebody from Ireland picked it up in Copenhagen or that the disease was picked up in a third country.

The bottom line is that Ireland is an open country. The links between this tiny sample of viruses is linked to international travel. This is normal in the early stages of an outbreak. You will see internal links later in the outbreak, he said.

We shouldnt be surprised that there isnt a single source for Ireland and the virus follows the traditional movement of our people.

Many people have blamed the decision by the Government not to shut down flights from northern Italy during the early days of the pandemic as a factor in the spread of the illness in Ireland, but Prof McInerney said there has not been enough genome sequencing done yet to make a definitive judgment on whether or not that was a factor.

The first 13 confirmed cases of coronavirus in Ireland were all people who had returned from northern Italy or who had contact with such people.

Since the first outbreak, foreign travel has become less a significant factor as the virus has spread throughout the community by person-to-person transmission.

Of the 3,894 cases confirmed so far, the percentage of those who contracted the virus abroad has dropped to 18 per cent.

Kevin Mitchell, associate professor of genetics and neuroscience at Trinity College Dublin, said the lineages of the virus make it easier to track its mutations and will help to understand how it travels within countries as well as between countries.

Its very useful for understanding how the virus is spreading. At early stages, it has mostly been being introduced by travel. But now it has changed to community spread in many places. Knowing what phase it is in informs the public health measures that should be taken, he said.

See more here:
Genetics shed light on origins of Irish strains of Covid-19 - The Irish Times

Indians do not have genetic protection against coronavirus, published research incorrectly interpreted – Deccan Herald

An opinion piece published onLivemintby Sandipan Debclaimedthat COVID-19 will not affect Indians as they have the genetics for a sturdier immune system.

When questioned on Twitter, the author, also a founder of Swarajya Magazine, cited a Nature Asia article titled, More immunity in Indian genes, as his source.

The Nature Asia article (2008), based on the research study by Du and colleagues (2008), published in the journal Genes & Immunity was conducted by a team of scientists from the University of California in Los Angeles (UCLA), USA, All India Institute of Medical Sciences, India (AIIMS), and National Marrow Donor Program (NMDP), USA.

CLAIM

More immunity in Indian genes The title of Nature Asia magazine article.

Our bodies have one of the toughest immune systems in the world. We have grown up surrounded by so much filth and pollution that our natural resilience is much stronger than people in the developed world. Sandipan Deb in Livemint.

For latest updates on coronavirus outbreak, click here

VERDICT

False.

FACT-CHECK

1. The Livemint article is based on a superficial understanding of the title of the Nature Asia article, not its text.

The Nature Asia article is titled More immunity genes in Indians. However, the article itself does not make any such claims that, on the basis of the research study quoted, that Indians will be protected from the coronavirus pandemic or other infections due to their biologically inherited resilience. It simply states that Indians may have more genes linked with immunity as per the data. Also, one of the authors of the article and the research study Rajalingam Raja wrote, Whether having more activating KIR genes is an advantage or disadvantage for Indians remains to be elucidated.

This means that the genes tested through this study are not a piece of conclusive evidence that the contested tougher immunity will be an advantage for Indians in any way.

2. The Nature Asiaarticle is based on a research study based on a single gene polymorphism in various ethnicities.

The Nature Asia article is based on a research study which relies upon a single gene KIR2DL5 polymorphism in many ethnicities including Indian, East Asian, white (Caucasian) and black (African Americans), suggesting that the gene is not unique to Indians only. Also, no evidence suggests that the presence of gene translates to gene expression or phenotypic change (e.g. higher immunity) in this case.

Nature Asia article based its claim on a gene polymorphism study by Du and colleagues (2008). Genetic polymorphism is the occurrence of multiple forms of a single gene which is expressed in the same population as a trait or a phenotype (Bull, 2004). It is similar, but not the same, as varying levels of pigmentation in eyes, hair or skin colour.

The study quoted showed the nature of polymorphism of one gene KIR2DL5 in four ethnic groups: Caucasians (European race, mostly white), Asian-Indians (South Asians), African-Americans and Asians (East Asians, i.e. Korean, Vietnamese, Japanese and Filipino).

Read:Coronavirus India update: State-wise total number of confirmed cases, deaths

KIR2DL5 (or CD158f) is the last identified KIR gene (the inhibitory receptor expressed on the surface of immune cells), with KIR2DL4, it makes up a structurally divergent lineage conserved in different primate species such as humans. The percentage frequency of this KIR2DL5 gene in Indians is used as an indicator of higher immunity.

The graph from the research study illustrates that the percentage frequency of KIR2DL5 (A and B, polymorphic forms of KIR2DL5 gene) is higher in Asian Indians than the other ethnic populations studied. However, the graph below from the same study suggests that the Individuals carrying the KIR2DL5 gene vary substantially among populations ranging in frequency from 35-85%. Thus, as per the authors conclusions, higher immunity can be found in every ethnicity ranging from 35-85% population, not just in Indians.

Also Read:

Hence, with such large variability in genes in each population, it is impossible to deduce that the researchers certainly found the KIR2DL5 gene more frequently in Indian ethnicities, as compared to other ethnicities.

Also, the research paper doesnt claim that this higher frequency in Asian-Indians population is linked to a better immune system or more natural killer cells in the body. In fact, there are no conclusions drawn on any ethnic group being genetically superior or inferior regarding immunity.

3. Is the occurrence of genes (KIR2DL5 gene) linked with immunity synonymous with its traits (tougher immunity)?

The occurrence of more genes in a population isnt always synonymous with better traits. This is mainly because a greater amount of genes doesnt always translate to a protein abundance, which consequently becomes a trait. That is, the presence of genes doesnt always lead to the presence of characteristic traits related to the expression of the gene.

Sometimes, polymorphic changes in natural killer cells can also be associated with a susceptibility towards certain diseases (Orange, 2002). Thus, more correlative studies should be conducted where a higher frequency of KIR2DL5 gene results in an increased immunity regardless of ethnicity.

4. Smaller sample size

The beneficial effects of higher frequency of a polymorphic gene in a population can only be established after detailed protein, genomics and evolutionary studies with large sample size. But in this study, only 96 Indian genomes were studied as opposed to 250 Caucasians. Hence, these higher percent frequencies of polymorphs KIR2DL5 gene could also be an artefact resulting from a smaller sample size.

Only 96 non-randomised samples for the Asian-Indian group were sourced from New Delhi, which is a minuscule representation for the Indian population. These sample sizes were further reduced after identification of KIR2DL5 positive individuals.

Also Read:Pune: Dead woman's test samples found coronavirus positive

Also, the Nature Asia article further claims that Indians gained the activating KIR (killer cell immunoglobulin-like receptors) genes because of natural selection to survive the environmental challenges during their pre-historic coastal migrations from Africa. This conclusion is not based on any evidence.

Similar claim in The Printopinion piece

Dr Mehra, former Dean of AIIMS, in his opinion piece in The Print mentions the results from the same study that includes SK Sharma of AIIMS, to make his claims about the genetic advantage of Indians over Caucasians with respect to immunity against the coronavirus. Additionally, Dr Mehra also included other factors that may give Indians advantage broad-based immunity due to overexposure to other pathogens, and epigenetic factors such as environment and consumption of Indian spices in cuisine. However, since the novelty of the virus and the increasing pathogenesis of SARS-CoV-2 in India, these claims remain without any research or evidence in Science.

CONCLUSION

The Nature Asia article published a misleading title on the basis of a genetics study which was termed inconclusive by the authors in their own research study. This title formed the basis of the Livemint article by Mr Deb.

The Nature Asia authors generalised their misleading article about Natural Killer cells (NK) to immunity genes. Natural killer cells are a small component of what makes up human immunity, not the expansive immune system.

Also Read:Old video falsely viral as Rahul and Priyanka Gandhi flouting coronavirus lockdown

Later, in the Livemint article, the Nature Asia article was used to claim a blanket superiority of the immune system of Indians. Mr Deb stated that Indians immune system is more robust than the people in the developed world to tackle the coronavirus pandemic.

Such dangerous opinion pieces with no understanding of the genetics of immunity have the potential to drive people to be careless with the protocols issued by the government on social distancing and other precautions or to encourage reckless behaviour during a critical situation.

Read more here:
Indians do not have genetic protection against coronavirus, published research incorrectly interpreted - Deccan Herald

Animal Genetics Market: Increase in Meat Consumption and Demand for High Quality Proteins to Drive Growth – BioSpace

Transparency Market Research (TMR) has published a new report titled Animal Genetics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20182026. According to the report, the global animal genetics market was valued at US$ 4,740.5 Mn in 2017. It is projected to expand at a CAGR of 6.0% from 2018 to 2026. Increase in meat consumption, demand for high quality proteins, and rise in purchasing power are likely to drive the animal genetics market from 2018 to 2026.

Genetic diversity provides the raw material for breed improvement and for the adaptation of livestock populations to changing environments and changing demands. Developments in genomic tools have allowed scientists to apply genome-wide information in the investigation of various aspects of livestock species. The animal genetics industry has witnessed robust expansion in the last two decades, particularly in developing countries where consumption of animal source food increased rapidly.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18995

Purchasing power is considered to be a key driver for livestock products. Lower-and middle-income consumers have a strong influence on consumption trends, as the effect of increased income on diet is greatest in this group. Increasing income in developing countries is an important factor that drives the consumption of livestock products, particularly meat. Poultry and dairy products have been found to have higher income elasticities of demand than other animal-source foods, i.e., the consumption levels are more responsive to income. This effect is particularly strong in low-income populations.

Furthermore, the animal genetics industry is pursuing alternative solutions in the fight against animal disease and suffering. These include using data and health-focused breeding indices and exploring breakthrough technology, including gene editing, which is likely to have a significant impact on farming and animal well-being. Adoption of semen sexing technology and IVF (invitro fertilization) is rising rapidly across dairy and beef herds. Access to such technology helps farmers to accelerate genetic progress in their herds.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=18995

Live animals segment to account for major share

In terms of product type, the live animals segment accounted for a dominant share of the animal genetics market in 2017. Growing urban population coupled with changes in consumer preference resulted in greater demand for assured food safety and quality. These developments favored large-scale production and processing of live animals. Moreover, increasing demand for meat has further propelled the segment. According to the Food and Agriculture Organization (FAO) of the United Nations, demand for food is expected to double food production in order to feed the global population, which is estimated to reach around 9.1 billion by 2050. Cost-effective production of safe, high-quality, animal protein is necessary to cater to this surge in demand.

Market in Asia Pacific to expand at a significant pace

North America held a major share of the global market, in terms of revenue. It is expected to maintain its position during the forecast period. North America is home to several key market players, such as Zoetis, Inc., Neogen Corporation, and VetGen, who have their headquarters in the U.S., where they generate significant sales. Hence, North America is a leading market for animal genetics, globally. High awareness about latest technologies and higher purchasing power are anticipated to boost the animal genetics market in North America. The animal genetics market in Asia Pacific is expected to expand at a rapid pace, primarily due to increasing disposable income, rising population and increasing urbanization. Asia Pacific is home to major pork producing countries such as China, Russia, and Japan.

Request for Discount on this Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=18995

Key players such as Genus plc, CRV Holding B.V., and Neogen Corporation to lead the market

The report also provides profiles of other major players operating in the global animal genetics market. Major players include Zoetis, Inc., Groupe Grimaud, Topigs Norsvin, VetGen, Animal Genetics Inc., and Hendrix Genetics BV.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key tohelp enterprises reach right decision.

ContactTransparency Market ResearchState Tower,90 State Street,Suite 700Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email:sales@transparencymarketresearch.comWebsite:https://www.transparencymarketresearch.com

View post:
Animal Genetics Market: Increase in Meat Consumption and Demand for High Quality Proteins to Drive Growth - BioSpace

Genetics expert condemns FG over alleged invitation of Chinese doctors to fight COVID-19 pandemic – Vanguard

A genetics expert of Novena University, Delta State, Prof Cyril Otoikhian

A genetics expert of Novena University, Delta State, Prof Cyril Otoikhian, has joined some Nigerians and organisations to condemn the Federal Government over the alleged invitation of Chinese doctors to lead in fight spread of Coronavirus, COVID-19, pandemic in the country.

Otoikhian who is Founder of EO Foundation, a non-governmental organisation that advocates stop on sickle cell transfer in Africa, said it is dangerous importing doctors and materials from countries with a

high burden of the virus that has killed thousands of their citizens, which calls for total rejection.

According to him Nigerian medical doctors and other health professionals have the expertise to tackle the spread of the virus if they will be equipped with necessary materials and incentives.

He said: Importing doctors and materials from a biochemical war zone to our country that is yet to record genuine and authenticated case is dangerous and may result in waking up the sleeping kettle of poisonous substances called COVID-19.

Our doctors are professional enough to handle any eventuality. All that we expect from the Federal Government and the Ministry of Health is to make available all necessary equipment and stop top government representatives from travelling to war zones.

It will be recalled that the Nigeria Union of Journalists, NUJ, also in a statement expressed worry and cautioned the Federal Government on bringing in Chinese medical doctors to the virus.

It also pleaded with the government to rescind its plan and stop the Chinese medial team from coming to the country, which alleged that the rapid increase of infected persons and deaths in Italy caused by the virus was during the arrival of Chinese doctors in that country.

Also, the Nigerian Association of Resident Doctors, NARD, decried the alleged move by the Federal Government to invite an 18-man Chinese team of medical experts made up of doctors and nurses to render assistance to Nigerians to stop the spread of the virus.

However, the Director-General, National Orientation Agency, NOA, Garba Abari, recently refuted claims and assertions made by some people and organizations over the alleged invitation of Chinese medical experts to lead in the fight against the deadly virus in Nigeria.

According to Abari the Chinese medical experts are only coming to share their experience on the approaches they used in the fighting outbreaks of the COVID-19 crisis in their country with the Nigeria Centre for Disease Control, NCDC.

Vanguard

Related

Read more here:
Genetics expert condemns FG over alleged invitation of Chinese doctors to fight COVID-19 pandemic - Vanguard

Those Who Purchased Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Have A 99% Loss To Show For It – Simply Wall St

This week we saw the Cancer Genetics, Inc. (NASDAQ:CGIX) share price climb by 17%. But that doesnt change the fact that the returns over the last half decade have been stomach churning. Like a ship taking on water, the share price has sunk 99% in that time. Its true that the recent bounce could signal the company is turning over a new leaf, but we are not so sure. The fundamental business performance will ultimately determine if the turnaround can be sustained.

We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you dont have to lose the lesson.

Check out our latest analysis for Cancer Genetics

Because Cancer Genetics made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesnt make profits, wed generally expect to see good revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

Over five years, Cancer Genetics grew its revenue at 14% per year. Thats a pretty good rate for a long time period. So the stock price fall of 59% per year seems pretty steep. The market can be a harsh master when your company is losing money and revenue growth disappoints.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

This free interactive report on Cancer Geneticss balance sheet strength is a great place to start, if you want to investigate the stock further.

We regret to report that Cancer Genetics shareholders are down 61% for the year. Unfortunately, thats worse than the broader market decline of 14%. Having said that, its inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last years performance caps off a bad run, with the shareholders facing a total loss of 59% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. Its always interesting to track share price performance over the longer term. But to understand Cancer Genetics better, we need to consider many other factors. For example, weve discovered 6 warning signs for Cancer Genetics (4 are a bit concerning!) that you should be aware of before investing here.

We will like Cancer Genetics better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

Go here to see the original:
Those Who Purchased Cancer Genetics (NASDAQ:CGIX) Shares Five Years Ago Have A 99% Loss To Show For It - Simply Wall St

When Will Fulgent Genetics, Inc. (NASDAQ:FLGT) Breakeven? – Simply Wall St

Fulgent Genetics, Inc.s (NASDAQ:FLGT): Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. The US$206m market-cap company announced a latest loss of -US$411.0k on 31 December 2019 for its most recent financial year result. As path to profitability is the topic on FLGTs investors mind, Ive decided to gauge market sentiment. In this article, I will touch on the expectations for FLGTs growth and when analysts expect the company to become profitable.

See our latest analysis for Fulgent Genetics

According to the 2 industry analysts covering FLGT, the consensus is breakeven is near. They expect the company to post a final loss in 2020, before turning a profit of US$3.4m in 2021. FLGT is therefore projected to breakeven around a couple of months from now! In order to meet this breakeven date, I calculated the rate at which FLGT must grow year-on-year. It turns out an average annual growth rate of 147% is expected, which is extremely buoyant. If this rate turns out to be too aggressive, FLGT may become profitable much later than analysts predict.

Underlying developments driving FLGTs growth isnt the focus of this broad overview, however, bear in mind that generally a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

One thing Id like to point out is that FLGT has no debt on its balance sheet, which is quite unusual for a cash-burning loss-making, growth company, which typically has high debt relative to its equity. This means that FLGT has been operating purely on its equity investment and has no debt burden. This aspect reduces the risk around investing in the loss-making company.

This article is not intended to be a comprehensive analysis on FLGT, so if you are interested in understanding the company at a deeper level, take a look at FLGTs company page on Simply Wall St. Ive also put together a list of relevant aspects you should further research:

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

Read the original:
When Will Fulgent Genetics, Inc. (NASDAQ:FLGT) Breakeven? - Simply Wall St

Genes and genetics explained – Better Health Channel

Your chromosomes contain the blueprint for your body your genes. Almost every cell in the human body contains a copy of this blueprint, mostly stored inside a special sac within the cell called the nucleus. Chromosomes are long strands of a chemical substance called deoxyribonucleic acid (DNA).

A DNA strand looks like a twisted ladder. The genes are like a series of letters strung along each edge. These letters are used like an instruction book. The letter sequence of each gene contains information on building specific molecules (such as proteins or hormones both essential to the growth and maintenance of the human body).

Although every cell has two copies of each gene, each cell needs only certain genes to be switched on in order to perform its particular functions. The unnecessary genes are switched off.

Sometimes, a gene contains a change that disrupts the genes instructions. A change in a gene can occur spontaneously (no known cause) or it can be inherited. Changes in the coding that makes a gene function can lead to a wide range of conditions.

Humans typically have 46 chromosomes in each cell of their body, made up of 22 paired chromosomes and two sex chromosomes. These chromosomes contain between 20,000 and 25,000 genes. New genes are being identified all the time.

The paired chromosomes are numbered from 1 to 22 according to size. (Chromosome number 1 is the biggest.) These non-sex chromosomes are called autosomes.

People usually have two copies of each chromosome. One copy is inherited from their mother (via the egg) and the other from their father (via the sperm). A sperm and an egg each contain one set of 23 chromosomes. When the sperm fertilises the egg, two copies of each chromosome are present (and therefore two copies of each gene), and so an embryo forms.

The chromosomes that determine the sex of the baby (X and Y chromosomes) are called sex chromosomes. Typically, the mothers egg contributes an X chromosome, and the fathers sperm provides either an X or a Y chromosome. A person with an XX pairing of sex chromosomes is biologically female, while a person with an XY pairing is biologically male.

As well as determining sex, the sex chromosomes carry genes that control other body functions. There are many genes located on the X chromosome, but only a few on the Y chromosome. Genes that are on the X chromosome are said to be X-linked. Genes that are on the Y chromosome are said to be Y-linked.

Parents pass on traits or characteristics, such as eye colour and blood type, to their children through their genes. Some health conditions and diseases can be passed on genetically too.

Sometimes, one characteristic has many different forms. For example, blood type can be A, B, AB or O. Changes (or variations) in the gene for that characteristic cause these different forms.

Each variation of a gene is called an allele (pronounced AL-eel). These two copies of the gene contained in your chromosomes influence the way your cells work.

The two alleles in a gene pair are inherited, one from each parent. Alleles interact with each other in different ways. These are called inheritance patterns. Examples of inheritance patterns include:

The most common interaction between alleles is a dominant/recessive relationship. An allele of a gene is said to be dominant when it effectively overrules the other (recessive) allele.

Eye colour and blood groups are both examples of dominant/recessive gene relationships.

The allele for brown eyes (B) is dominant over the allele for blue eyes (b). So, if you have one allele for brown eyes and one allele for blue eyes (Bb), your eyes will be brown. (This is also the case if you have two alleles for brown eyes, BB.) However, if both alleles are for the recessive trait (in this case, blue eyes, bb) you will inherit blue eyes.

For blood groups, the alleles are A, B and O. The A allele is dominant over the O allele. So, a person with one A allele and one O allele (AO) has blood group A. Blood group A is said to have a dominant inheritance pattern over blood group O.

If a mother has the alleles A and O (AO), her blood group will be A because the A allele is dominant. If the father has two O alleles (OO), he has the blood group O. For each child that couple has, each parent will pass on one or the other of those two alleles. This is shown in figure 1. This means that each one of their children has a 50 per cent chance of having blood group A (AO) and a 50 per cent chance of having blood group O (OO), depending on which alleles they inherit.

Figure 1 -Fathers blood group(OO, group O)

AO

(group A)

AO

(group A)

The combination of alleles that you have is called your genotype (e.g. AO). The observable trait that you have in this case blood group A is your phenotype.

If a person has one changed (q) and one unchanged (Q) copy of a gene, and they do not have the condition associated with that gene change, they are said to be a carrier of that condition. The condition is said to have a recessive inheritance pattern it is not expressed if there is a functioning copy of the gene present.

If two people are carriers (Qq) of the same recessive genetic condition, there is a 25 per cent (or one in four) chance that they may both pass the changed copy of the gene on to their child (qq, see figure 2.) As the child then does not have an unchanged, fully functioning copy of the gene, they will develop the condition.

There is also a 25 per cent chance that each child of the same parents may be unaffected, and a 50 per cent chance that they may be carriers of the condition.

Figure 2 -Father (carrier)

QQ(unaffected)

Qq(carrier)

Recessive genetic conditions are more likely to arise if two parents are related, although they are still quite rare. Examples of autosomal recessive genetic conditions include cystic fibrosisand phenylketonuria (PKU).

Not all genes are either dominant or recessive. Sometimes, each allele in the gene pair carries equal weight and will show up as a combined physical characteristic. For example, with blood groups, the A allele is as strong as the B allele. The A and B alleles are said to be co-dominant. Someone with one copy of A and one copy of B has the blood group AB.

The inheritance pattern of children from parents with blood groups B (BO) and A (AO) is given in figure 3.

Each one of their children has a 25 per cent chance of having blood group AB (AB), A (AO), B (BO) or O (OO), depending on which alleles they inherit.

Figure 3 -Fathers blood group -(group B)

AB

(group AB)

AO

(group A)

A cell reproduces by copying its genetic information then splitting in half, forming two individual cells. Occasionally, an alteration occurs in this process, causing a genetic change.

When this happens, chemical messages sent to the cell may also change. This spontaneous genetic change can cause issues in the way the persons body functions.

Sperm and egg cells are known as germ cells. Every other cell in the body is called somatic (meaning relating to the body).

If a change in a gene happens spontaneously in a persons somatic cells, they may develop the condition related to that gene change, but wont pass it on to their children. For example, skin cancer can be caused by a build-up of spontaneous changes in genes in the skin cells caused by damage from UV radiation. Other causes of spontaneous gene changes in somatic cells include exposure to chemicals and cigarette smoke. However, if the gene change occurs in a persons germ cells, that persons children have a chance of inheriting the altered gene.

About half of the Australian population will be affected at some point in their life by a condition that is at least partly genetic in origin. Scientists estimate that more than 10,000 conditions are caused by changes in single genes.

The three ways in which genetic conditions can arise are:

Having a genetic susceptibility to a condition does not mean that you will develop the condition. It means that you are at increased risk of developing it if certain environmental factors, such as diet or exposure to chemicals, trigger its onset. If these triggering conditions do not occur, you may never develop the condition.

Some types of cancer are triggered by environmental factors such as diet and lifestyle. For example, prolonged exposure to the sun is linked to melanoma. Avoiding such triggers means significantly reducing the risks.

Related parents are more likely than unrelated parents to have children with health problems or genetic conditions. This is because the two parents share one or more common ancestors and so carry some of the same genetic material. If both partners carry the same inherited gene change, their children are more likely to have a genetic condition.

Related couples are recommended to seek advice from a clinical genetics service if their family has a history of a genetic condition.

If a family member has been diagnosed with a genetic condition, or if you know that a genetic condition runs in your family, it can be helpful to speak to a genetic counsellor.Genetic counsellors are health professionals qualified in both counselling and genetics. As well as providing emotional support, they can help you to understand a genetic condition and what causes it, how it is inherited (if it is), and what a diagnosis means for you and your family.

Genetic counsellors are trained to provide information and support that is sensitive to your family circumstances, culture and beliefs.

Genetic services in Victoria provide genetic consultation, counselling, testing and diagnostic services for children, adults, families, and prospective parents. They also provide referral to community resources, including support groups, if needed.

See original here:
Genes and genetics explained - Better Health Channel

Unlocking the Genetics of Autism Spectrum Disorder – TMC News – Texas Medical Center News

Cason McKee was diagnosed with autism when he was 3 years old.

Both of his parents worked with autistic children in the Texas school system, so they saw it coming.

Early on, when we first started noticing a difference in him, he was a typical 18-month old, said Shannon McKee, Casons mother. But between 18 months and 2 years, he started to lose his language and his interest in language. It happened gradually.

At Casons second birthday party, McKee realized that her son wasnt engaging with his friends. He doesnt even carethat his friends are here, she thought.

A light bulb went off in my head, she said.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::Looking for the latest on the CORONAVIRUS? Read our daily updates HERE.::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Casons diagnosis of ASD (autism spectrum disorder) unleashed a host of questions for Shannon and Michael McKee, who began searching for the best therapies and pro- grams for their son. Once they got a grasp on their own situation, it became increasingly important for them to help other families who had received an ASD diagnosis. One of the best ways to do that, they realized, was to participate in research that could unlock some of the genetic mysteries surrounding the disorder, which affects communication and social interaction.

In 2016, the McKees were among the first families to enroll in the national SPARK for Autism study, a landmark project that aims to accelerate the pace of autism research and answer myriad genetic questions about the disorder.

More specifically, that 50,000 actually refers to triosto an individual with autism and both biological parents, Kochel explained. To date, SPARK has enrolled close to 23,000 families in a database that allows investigators to search for and identify genetic trends and similarities.

Its open to everyone, Kochel said. Basically, families enroll online. It takes about 20 to 30 minutes. They have the option to consent to providing a genetic sample.

For families who consent, a saliva kit is mailed to their home, with instructions for its use and return. Families also consent to whether or not they want to see the results of a genetic finding, if one is made.

Today, there are over 1,000 genes that have been associated with autism, and part of what SPARK is doing is to help identify more genetic causes of autism, Kochel said. We do know that autism is largely caused by genetic factors, yet when you go to get a clinical genetic test today, only a fraction of kids come back with a finding. But we still believe that theres more there, genetically, and were look- ing for it. Its just going to take some time.

SPARK hopes to identify small groups of people diagnosed with ASD who have the same genetic differencesdifferences researchers didnt know about before.

The study is a way for us to help identify those people and get them together and think about what would be valuable to learn about this particular group, Kochel said. We call it a genet- ics first approach. We might then have next-step studies that would convene those folks and say: You all have the same genetic difference. Can we work with you to see what else is similar with you? It might be certain medical conditions or other psychiatric diagnoses, things like that.

Excerpt from:
Unlocking the Genetics of Autism Spectrum Disorder - TMC News - Texas Medical Center News

RESEARCH THAT MATTERS: Paying attention to the genetic basis for hearing loss key to improving quality of life – TheChronicleHerald.ca

At 12- or 13-years of age, a good student turns bad. He doesnt seem to listen in class. Hes restless.

The boy in this story is a real one. He grew up in an isolated community on the South Coast of Newfoundland, where the genetic lines run deep through many generations.

Dr. Terry-Lynn Young, a member of the gene dream team at Memorial University in St. Johns, first heard about the lad more than 20 years ago.

He started acting out. A hearing test showed he had trouble hearing low frequency sounds. He had a male teacher, and he simply couldnt hear him well.

It turned out the hearing loss was a genetic legacy and the cause of the sudden onset of his troubles at school.

Young was a postdoctoral fellow and member of the Memorial team that worked with members of the boys family, several of whom wore hearing aids.

Anne Griffin, an audiologist on Youngs team confirmed low-frequency hearing loss in family members. Unfortunately, the hearing aids had been tuned to amplify high-pitched sounds.

The audiologist adjusted the aids, cranking up the volume of low frequency sounds. Grown men came out of her office with tears in their eyes. They could finally hear, says Young, a leading geneticist who spent her formative years in St. Anthony, at the top of Newfoundlands Great Northern Peninsula.

The Memorial team conducted genetic testing, finally finding the gene that had impacted the familys hearing for eight generations.

In 2001, Young and others published the results in Human Molecular Genetics, a journal published by Oxford University Press. Almost two decades later, she is incredibly frustrated that the key insight of that peer-review article has not made its way widely into clinical practice.

The insight was that a patients genetics should form the basis of care for hearing loss from each according to his genome, to each according to his needs.

Care for hearing loss, based on genetic testing, is not complicated as it sounds, either. In some cases, audiologists can simply fine tune hearing devices the same way you do your stereo turn down the bass, turn up the treble, and deliver more sound to the right speaker if required.

But the genetic understanding of hearing loss now goes deeper than that, Dr. Young said.

We can tell if the hearing loss is in one ear or both ears, if it gets worse or stays the same over time, if it is high frequency or low frequency loss, if it is likely to impact people when they are older or younger. Its like we know each and every cell.

The underlying health care issue is urgent. Hearing loss is the most common sensory disorder of all in humans, she says, and is now linked to social isolation, dementia in older people, and learning problems in children.

Young describes the cochlea - the snail shaped portion of the inner ear that converts sound vibrations into nerve impulses to the brain as elegant and beautiful. Its a triumph of genetics that the cochlear system is so well-understood. Its a failure of health care delivery that this understanding isnt better reflected in clinical practice.

A good start at improving care delivery would be easier public access to genetic testing, which can be done from a single strand of hair or saliva sample just like on a TV cop show. How do we roll out genetic testing at Costco?, Young asked.

Another step forward would be better training in genetics for student audiologists. Thats sorely lacking today. As a result, audiologists use standard hearing tests, which often fall short of what is needed and as the family from the South Coast of Newfoundland learned the hard way.

As part of Memorials team of geneticists, Young knows that genetic breakthroughs can sometimes result in better patient care in a hurry.

She and her colleagues identified a genetic anomaly in a Newfoundland family that caused sudden cardiac arrest and often early death especially among males. Your first symptom could be your last, she said.

Cardiologists implanted defibrillators in these patients - to restart the heart in case of an incident before Youngs team found the underlying gene.

That was brilliant, she said. The caregivers were out in front of the genetic knowledge, not trailing it.

Young is determined to see genetics play a more significant role in treating hearing care as well.

Im going to beat this drum loud enough that everyone hears she said.

Research That Matters is written by Jim Meek, Public Affairs Atlantic, on behalf of the Association of Atlantic Universities (AAU).

RELATED:

More here:
RESEARCH THAT MATTERS: Paying attention to the genetic basis for hearing loss key to improving quality of life - TheChronicleHerald.ca